CTOs on the Move

ForeverGreen

www.forevergreen.org

 
ForeverGreen Worldwide Corporation develops, manufactures and distributes an expansive line of all natural whole foods and products to North America, Australia, Europe, Asia, Africa and South America, including their new global Xpress offering Prodigy-5. Additional products include PowerStrips, SolarStrips and BeautyStrips. They also offer their North America weight-management line Ketopia, along with FrequenSea, a whole-food beverage with industry exclusive marine phytoplankton, immune support and weight management products, and Pulse-8 powdered L-arginine formula.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details
Dan Eastman
Chief Information Officer Profile

Similar Companies

ICS Connect

ICS Connect is a Frisco, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Comprehensive Healthcare

Comprehensive Healthcare is a private nonprofit organization delivering recovery services throughout Yakima, Kittitas, Klickitat and Walla Walla counties, and in portions of Benton & Franklin counties. Services include inpatient and outpatient treatmen...

RS Design

RS Design is a Hawthorne, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.

Prairie Health Ventures

Prairie Health Ventures is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.